Engineering the AAV capsid to evade immune responses.
Sign Up to like & getrecommendations! Published in 2019 at "Current opinion in biotechnology"
DOI: 10.1016/j.copbio.2019.01.002
Abstract: Gene therapy is progressively emerging as a promising and powerful therapeutic modality, and adeno-associated virus (AAV) is a major delivery vehicle for such therapies. Among the most significant challenges that limit AAV's utility, however, is… read more here.
Keywords: capsid evade; aav; engineering; aav capsid ... See more keywords